Global trends
The healthcare landscape across the world is in quite a multi-polar state at the moment. What this means is that globally there isn’t a single trend that dominates the sector. In the developed world, the economic slump pushed governments to implement drastic measures to control healthcare costs. This has had a significant impact on pharmaceutical companies as they see more of their portfolio hemorrhage value as prices fall around the world. This development opened up avenues of opportunities for generic players, many from India as well as a few global ones as well.
What I find very interesting in this geography is that on one hand, governments increasingly became picky about supporting high priced patented products that bring only incremental value compared to off-patent products in the same category. On the other, they opened up their coffers to products that solve niche problems and unmet needs. It is…
View original post 1,258 more words
bio10blog 